Enabling you to identify and mitigate the intrinsic risk in your operations, supply chains and business processes.
Evaluating how your products and services meet and exceed quality, safety, sustainability and performance standards.
Validating the specifications, value and safety of your raw materials, products and assets.
A Complimentary Intertek Cantox Webinar
Drug discovery and development is an intricate process which operates in a highly regulated environment. All drug development programs involve combining together many different disciplines including pharmacology, drug metabolism & pharmacokinetics, toxicology, chemistry & manufacturing (CMC), and clinical research and operations. The success of a drug development program is only as good as the weakest link in this complex and interrelated development chain. The submission of incomplete, inaccurate, or scientifically deficient data to a regulatory authority will result in rejection/clinical hold and cost a company and its investors significant time and money.
As drug development consultants, Intertek Cantox see the same types of missteps in early drug development being perpetrated by a multitude of early stage companies developing biologic and small molecule therapeutics across a wide variety of therapeutic areas. This webinar addresses ways to avoid common mistakes and is of relevance to scientists, entrepreneurs, investors, and drug development executives alike.